- Home
- NATR vs NLSP Comparison
NATR vs NLSP Comparison
Compare NATR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- NLSP
- Stock Information
- Founded
- NATR 1972
- NLSP 2015
- Country
- NATR United States
- NLSP Switzerland
- Employees
- NATR N/A
- NLSP N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- NATR Health Care
- NLSP Health Care
- Exchange
- NATR Nasdaq
- NLSP Nasdaq
- Market Cap
- NATR N/A
- NLSP 5.2M
- IPO Year
- NATR N/A
- NLSP 2021
- Fundamental
- Price
- NATR $15.00
- NLSP $1.95
- Analyst Decision
- NATR Strong Buy
- NLSP
- Analyst Count
- NATR 2
- NLSP 0
- Target Price
- NATR $19.50
- NLSP N/A
- AVG Volume (30 Days)
- NATR 47.1K
- NLSP 535.3K
- Earning Date
- NATR 11-07-2024
- NLSP 12-31-2024
- Dividend Yield
- NATR N/A
- NLSP N/A
- EPS Growth
- NATR 114.95
- NLSP N/A
- EPS
- NATR 0.88
- NLSP N/A
- Revenue
- NATR $445,095,000.00
- NLSP N/A
- Revenue This Year
- NATR $2.07
- NLSP N/A
- Revenue Next Year
- NATR $2.62
- NLSP N/A
- P/E Ratio
- NATR $16.97
- NLSP N/A
- Revenue Growth
- NATR 1.36
- NLSP N/A
- 52 Week Low
- NATR $10.81
- NLSP $1.73
- 52 Week High
- NATR $21.72
- NLSP $24.32
- Technical
- Relative Strength Index (RSI)
- NATR 42.45
- NLSP 34.15
- Support Level
- NATR $14.90
- NLSP $1.73
- Resistance Level
- NATR $15.88
- NLSP $2.79
- Average True Range (ATR)
- NATR 0.62
- NLSP 0.36
- MACD
- NATR -0.21
- NLSP 0.04
- Stochastic Oscillator
- NATR 5.24
- NLSP 14.67
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.